-
Mashup Score: 45A New Medication for Non–Cystic Fibrosis Bronchiectasis - 1 month(s) ago
Non–cystic fibrosis (CF) bronchiectasis is a frustrating disease that is associated with poor quality of life, and exacerbations can accelerate
Source: www.jwatch.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0
Patients treated for acute exacerbation of bronchiectasis in NYC public hospitals are diverse, but care disparities have yet to be identified.
Source: www.pulmonologyadvisor.comCategories: General Medicine News, PulmonologyTweet-
Among patients seen for #bronchiectasis acute exacerbations at NYC public hospitals, admission rates did not vary significantly by race/ethnicity (59% White, 55% Black, 46% Asian). https://t.co/UHRkZepgZd
-
-
Mashup Score: 37Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study - 6 month(s) ago
The clinical characteristics of patients with bronchiectasis in China show differences compared with cohorts in Europe and India. Bronchiectasis is more severe with a higher burden of exacerbations in lower-income regions. The management of patients with bronchiectasis in China urgently needs standardisation and improvement.
Source: www.thelancet.comCategories: General Medicine News, PulmonologyTweet-
New Article: Baseline characteristics of patients in the Chinese #Bronchiectasis Registry (BE-China): a multicentre cohort study Characteristics of Chinese bronchiectasis patients show differences compared with cohorts in Europe & India https://t.co/3RWsBPy9OH @ProfJDChalmers https://t.co/OTzan0nrQj
-
-
Mashup Score: 30Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study - 12 month(s) ago
Rationale: Chest computed tomography (CT) scans are essential to diagnose and monitor bronchiectasis (BE). To date, few quantitative data are available about the nature and extent of structural lun…
Source: www.atsjournals.orgCategories: General Medicine News, PulmonologyTweet-
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study Factors associated with worse structural lung abnormalities in #bronchiectasis included lower FEV1 and Pseudomonas and NTM infection @Profjdchalmers 🔗 https://t.co/WRmJsPYW9F https://t.co/melTpBd8Zj
-
-
Mashup Score: 44
Rationale: Bronchiectasis is characterized by acute exacerbations, but the biological mechanisms underlying these events are poorly characterized. Objectives: To investigate the inflammatory and mi…
Source: www.atsjournals.orgCategories: General Medicine News, PulmonologyTweet-
Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study Molecular characterization of #bronchiectasis exacerbations reveals a key role for viruses, particularly rhinovirus, and inflammatory subtypes @profjdchalmers 🔗 https://t.co/6GC2CWiQ4c https://t.co/0EQBn41nIr
-
-
Mashup Score: 15The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC) - 1 year(s) ago
Rationale: COPD and bronchiectasis are commonly reported together. Studies report varying impacts of co-diagnosis on outcomes, which may be related to different definitions of disease used across s…
Source: www.atsjournals.orgCategories: General Medicine News, PulmonologyTweet-
The Association between Bronchiectasis and COPD: Data from EMBARC In a European registry of patients with #bronchiectasis, COPD was common and associated with increased exacerbations and mortality @EvaPolverino @alibertistefano @profjdchalmers 🔗 https://t.co/Qpg4nmFDw8 https://t.co/6byTAfMovd
-
-
Mashup Score: 9
Rationale: Nontuberculous mycobacteria (NTM) are prevalent among patients with bronchiectasis. However, the long-term natural history of patients with NTM and bronchiectasis is not well described. …
Source: www.atsjournals.orgCategories: General Medicine News, PulmonologyTweet-
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients Exacerbations, hospitalizations, loss of lung function, and mortality were similar across 5 years in #bronchiectasis patients with or without nontuberculous mycobacteria https://t.co/7VdKG4kbMN https://t.co/wqXfQ3jWRo
-
-
Mashup Score: 0
Subtypes of bronchiectasis exacerbations are associated with distinct inflammatory and microbial profiles.
Source: www.pulmonologyadvisor.comCategories: General Medicine News, PulmonologyTweet-
Subtypes of #bronchiectasis exacerbations are associated with distinct inflammatory and microbial profiles, researchers from the @atscommunity reported. https://t.co/2ScqxtcVui
-
-
Mashup Score: 10
Among patients with bronchiectasis, disease severity was higher with a blood eosinophil count less than 50 cells/L or higher than 300 cells/L, according to results published in CHEST.Further, between the two groups, the group with the lower count had greater disease and exacerbation severity, according to researchers.
Source: www.healio.comCategories: General Medicine News, Allergy-ImmunologyTweet-
Low or high eosinophil counts are associated with more severe bronchiectasis and exacerbations. Disease severity tends to be elevated when blood eosinophil count is below 50 cells/μL or exceeds 300 cells/μL, as per findings in CHEST. #Bronchiectasis https://t.co/pA7mMzwCOu https://t.co/kVJoyuf3k8
-
-
Mashup Score: 30A core outcome set for bronchiectasis in children and adolescents for use in clinical research: an international consensus study - 2 year(s) ago
Improving the treatment of non-cystic fibrosis bronchiectasis in children and adolescents requires high-quality research with outcomes that meet study objectives and are meaningful for patients and their parents and caregivers. In the absence of systematic reviews or agreement on the health outcomes that should be measured in paediatric bronchiectasis, we established an international, multidisciplinary panel of experts to develop a core outcome set (COS) that incorporates patient and parent perspectives.
Source: www.thelancet.comCategories: General Medicine News, PulmonologyTweet-
NEW Position Paper—A core outcome set for #bronchiectasis in children and adolescents for use in clinical research From Anne Chang and colleagues @Child_BEAR_Net: https://t.co/LY5kZSaVsV
-
Brensocatib: A new medication for non–cystic fibrosis bronchiectasis https://t.co/YlqJR8SqsQ #bronchiectasis @NEJM https://t.co/7CXt6uDbHn